Enter your search term below:
ISCT Mesenchymal Stroma Cell (MSC) Committee Mesenchymal stromal cells (MSCs) are among the most widely used cellular products worldwide, yet the field still lacks shared, testable answers about what happens to these cells after they are administered/delivered. A new ISCT MSC Committee...
Andrew Haskell, PhD, MLS, CT(ASCP), CMM, BCM, QLSCM ISCT North America LRA Committee ASPR United States Lynn Csontos, RAC ISCT North America LRA Committee STEMCELL Technologies Canada Kevin Bosse, PhD, RAC-US, CABP(H) Chair, ISCT North America LRA Committee ISCT North America Regional...
Fajar Dumadi, BSc ISCT Canada Committee for Advanced Therapies (CAT) Agendas for recent meetings Agenda for the meeting on 18-20 March 2026 https://www.ema.europa.eu/en/documents/agenda/agenda-cat-meeting-18-20-march-2026 en.pdf Agenda for the meeting on 18-20 February...
Mirja Krause-Onwukwe, PhD, MSc ISCT ANZ LRA Committee Member Australia Gabrielle O'Sullivan, PhD ISCT ANZ LRA Committee Co-Chair Australia Australia and New Zealand Regulatory Updates Medsafe Medsafe Guidance on Advanced Therapies – As an outcome of the consultation...
Fajar Dumadi, BSc Specialist, Regulatory Program ISCT Canada With great excitement, the International Society for Cell & Gene Therapy (ISCT) publishes its fifth Global Regulatory Report in collaboration with Clarivate ™. This report offers a comprehensive global overview of the cell...
Scaling cryopreservation has become a major obstacle in the path toward commercializing cell and gene therapies. In a recent survey conducted by the ISCT Cold Chain Working Group, respondents identified “ability to process at large scale” as the most significant challenge facing cryopreservation...
Apr 27, 2026 | 07:00 - 08:00 PT
Miguel Forte, MD, PhD ISCT President MC4TX Belgium As a well-established tradition, ISCT will hold its annual meeting at the beginning of May. This year we will gather in Dublin from the 6th to the 10th of May. It is an unmissable event as the largest global cell and gene therapy...
Joaquim Vives, PhD Contributing Editor, ISCT Telegraft Banc de Sang i Teixits Spain Today, as I reflect on our recent milestones in Madrid and Bangkok, I am struck by a linguistic duality: while the world outside our labs feels like a threat , the scientific community we have built is a...
Dr. Adaeze Ekwe, PhD Junior Associate Editor, ISCT Telegraft Australia The first quarter of 2026 has been a pivotal period for the global cell and gene therapy (CGT) sector, defined by clinical milestones, regulatory reforms and the launch of next-generation manufacturing hubs. These...
Jan 12, 2026 07:00 - May 09, 2026 16:00 PT